Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Michael Ferguson being referenced
The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Ferguson | 81 | 7 | 8 | 30 | 24 | 6 | 118 | |
| Joel W. Sher | 79 | 52 | 3 | 35 | 10 | 7 | 232 | |
| Wesley Vermaelen | 118 | 18 | 4 | 44 | 4 | 6 | 217 | |
| Ahmad Yamin Abdul Rahman | 80 | 2 | 33 | 10 | 9 | 138 | ||
| Jonathan Mercier | 73 | 1 | 2 | 39 | 8 | 7 | 173 | |
| Peter Husemann | 149 | 14 | 2 | 44 | 9 | 5 | 213 | |
| Eleni Karinou | 143 | 9 | 5 | 17 | 13 | 7 | 207 | |
| James K. L. Holt | 126 | 5 | 6 | 7 | 57 | 4 | 242 | |
| Marie Glavier | 54 | 6 | 1 | 58 | 38 | 6 | 126 | |
| Alexandre Renaux | 104 | 3 | 38 | 8 | 6 | 211 | ||
| Xiaobo Ke | 99 | 2 | 3 | 8 | 19 | 7 | 174 |
All Works
Login with ORCID to disown or claim papers
Loading papers...